On May 22, the House Transportation and Infrastructure Committee approved the BUILD America 250 Act, a five-year surface transportation reauthorization bill intended to replace the Infrastructure Investment and Jobs Act (IIJA), which expires on September 30, 2026. In addition
Sidley Austin LLP
Sidley Austin LLP is a global law firm that publishes detailed legal analysis and commentary primarily focused on corporate governance, securities litigation, regulatory compliance, and related litigation matters. Its blog content often covers court decisions, regulatory developments, and best practices affecting corporate charters, bylaws, and compliance risks. The firm provides insights into jurisdictional issues, whistleblower implications, and evolving regulatory frameworks impacting financial institutions, pharmaceutical pricing, and digital regulations. Sidley Austin's publications serve legal professionals and corporate clients seeking updates and expert perspectives on complex legal and regulatory challenges.
Website:
https://sidley.com
Latest from Sidley Austin LLP - Page 8
Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN Deals
On May 6, 2026, the White House Council of Economic Advisors (CEA)[1] discretely released the first report quantifying its view of the projected savings generated by the administration’s Most-Favored-Nation (MFN) drug pricing policy framework, based on existing MFN pricing agreements…
New York Department of Financial Services Issues Coordinated Guidance on Frontier AI Cybersecurity Risks
On May 21, 2026, the New York State Department of Financial Services (“DFS”) issued two coordinated Industry Letters: a letter on Heightened Cybersecurity Risks Associated with Frontier AI Models (the “AI Advisory”) and accompanying Guidance on Measures Regulated Entities Should…
DOJ Announces Accelerated Review of FCA Qui Tams Alleging Fraud Against State-Administered Benefits Programs
It is not business as usual at DOJ. In the latest announcement related to the Department’s efforts to fight alleged fraud, on May 27, 2026, Assistant Attorney General Brett Shumate issued a memorandum directing DOJ’s Civil Division and U.S. Attorneys’…
Chambers 2026 Global Practice Guide for Artificial Intelligence
The Chambers 2026 Global Practice Guide for Artificial Intelligence provides the latest legal information on the rapidly evolving AI landscape, covering the commercial use of AI across key industries, AI-specific legislation and regulation, government and regulatory oversight, generative AI, agentic AI systems…
Fake Corporate Records, No Control: Court of Chancery Rejects Control Claim Under Section 225
In Berg v. Bar Lavi, the Delaware Court of Chancery rejected a claim of control in a Section 225 proceeding where the plaintiff relied on documents the Court found were fabricated. After trial, the Court concluded that the purported stock…
DOJ and Texas AG Announce First Settlement in National Investigation of Gender-Affirming Care for Minors
On May 15, 2026, the U.S. Department of Justice (“DOJ”) and Texas Attorney General Ken Paxton announced agreements with Texas Children’s Hospital (“TCH”) resolving allegations related to TCH’s provision of gender-affirming care to minors. The matter marks the first publicly…
EPA Proposes Two-Year Delay of Biden-Era Vehicle Emissions Standards
On May 14, 2026, the U.S. Environmental Protection Agency (EPA) announced that it is reconsidering the criteria pollutant standards for new light- and medium-duty vehicles. The first phase of EPA’s proposal would push back the phase-in schedule of the “Tier…
FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight Paradigm
Recent United States Food and Drug Administration (FDA) announcements continue to highlight the agency’s increasing development and use of artificial intelligence. Earlier this month, FDA announced the launch of the latest version of Elsa – the internal AI solution it…
Vice President and CMS Announce Suite of New Administrative Actions to Further Federal Anti-Fraud Health Care Initiatives
Last week, the White House and CMS announced a set of new administrative actions to further the Administration’s anti-fraud mission, including in particular CMS’s CRUSH (Comprehensive Regulations to Uncover Suspicious Healthcare) initiative, announced earlier this year. At a May 13,…